FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023245918> ?p ?o ?g. }

• W2023245918 endingPage "236" @default.
• W2023245918 startingPage "226" @default.
• W2023245918 abstract "Carboxyethylgermanium sesquioxide (Ge-132) is an organogermanium compound known to exert biological activities, such as antioxidant and anticancer effects. In this study, we investigated the effect of Ge-132 on the IVM of porcine oocytes via analysis of nuclear maturation, intracellular glutathione (GSH) and reactive oxygen species (ROS) levels, and subsequent embryonic development after parthenogenetic activation (PA) and IVF. After 40 hours of IVM, no significant difference in nuclear maturation was observed in the 100, 200, and 400 μg/mL of Ge-132 treatment groups (89.9%, 91.3%, and 90.4%, respectively) compared with the control group (89.0%). However, intracellular GSH levels in oocytes treated with 200 μg/mL of Ge-132 increased significantly (P < 0.05), and the 200 and 400 μg/mL of Ge-132 treatment groups exhibited a significant (P < 0.05) decrease in intracellular ROS levels compared with the control group. Oocytes matured with 200 and 400 μg/mL of Ge-132 during IVM displayed significantly higher cleavage rates (78.7% and 82.7% vs. 67.5%, respectively), and the 200 μg/mL of Ge-132 treatment group displayed higher blastocyst formation rates and greater total cell numbers after PA (59.5% and 67.8 vs. 38.2% and 55.3, respectively) than the control group. Furthermore, oocytes matured with 200 μg/mL of Ge-132 during IVM failed to display significantly higher blastocyst formation rates (31.6% vs. 36.7%) but exhibited greater total cell numbers after IVF (71.5 vs. 101.3, respectively) than the control group. We also found that the Ge-132-treated oocytes showed significantly higher messenger RNA (mRNA) expression levels of the oxidative-related gene Nrf-2 and lower mRNA expression levels of the proapoptotic gene Bax than the control group (P < 0.05). In conclusion, our results suggest that treatment with Ge-132 during IVM improves the developmental potential of PA and IVF porcine embryos by increasing the intracellular GSH levels, thereby decreasing the intracellular ROS levels and reducing oxidative stress-induced apoptosis, thereby regulating the mRNA expression of oocytes during oocyte maturation." @default.
• W2023245918 created "2016-06-24" @default.
• W2023245918 creator A5003181313 @default.
• W2023245918 creator A5007789858 @default.
• W2023245918 creator A5051333435 @default.
• W2023245918 creator A5083240638 @default.
• W2023245918 creator A5086987446 @default.
• W2023245918 date "2015-07-01" @default.
• W2023245918 modified "2023-10-16" @default.
• W2023245918 title "Antioxidative effect of carboxyethylgermanium sesquioxide (Ge-132) on IVM of porcine oocytes and subsequent embryonic development after parthenogenetic activation and IVF" @default.
• W2023245918 cites W1959708371 @default.
• W2023245918 cites W1979209667 @default.
• W2023245918 cites W1990582969 @default.
• W2023245918 cites W1998703307 @default.
• W2023245918 cites W2000153618 @default.
• W2023245918 cites W2002248161 @default.
• W2023245918 cites W2003607285 @default.
• W2023245918 cites W2008235964 @default.
• W2023245918 cites W2009455793 @default.
• W2023245918 cites W2012724807 @default.
• W2023245918 cites W2018086467 @default.
• W2023245918 cites W2019379404 @default.
• W2023245918 cites W2019563519 @default.
• W2023245918 cites W2023427185 @default.
• W2023245918 cites W2027651810 @default.
• W2023245918 cites W2030525575 @default.
• W2023245918 cites W2031661391 @default.
• W2023245918 cites W2034763955 @default.
• W2023245918 cites W2037153710 @default.
• W2023245918 cites W2043111473 @default.
• W2023245918 cites W2051258629 @default.
• W2023245918 cites W2056427748 @default.
• W2023245918 cites W2058309800 @default.
• W2023245918 cites W2061173535 @default.
• W2023245918 cites W2063546301 @default.
• W2023245918 cites W2068507850 @default.
• W2023245918 cites W2069548177 @default.
• W2023245918 cites W2075178580 @default.
• W2023245918 cites W2079464266 @default.
• W2023245918 cites W2101861123 @default.
• W2023245918 cites W2105754268 @default.
• W2023245918 cites W2106868003 @default.
• W2023245918 cites W2120097046 @default.
• W2023245918 cites W2122339603 @default.
• W2023245918 cites W2122529144 @default.
• W2023245918 cites W2123145617 @default.
• W2023245918 cites W2134414426 @default.
• W2023245918 cites W2134872883 @default.
• W2023245918 cites W2143101809 @default.
• W2023245918 cites W2146558971 @default.
• W2023245918 cites W2148125367 @default.
• W2023245918 cites W2149116147 @default.
• W2023245918 cites W2156701434 @default.
• W2023245918 cites W2159274932 @default.
• W2023245918 cites W2161982997 @default.
• W2023245918 cites W2167083281 @default.
• W2023245918 cites W2168139864 @default.
• W2023245918 doi "https://doi.org/10.1016/j.theriogenology.2015.03.006" @default.
• W2023245918 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25913277" @default.
• W2023245918 hasPublicationYear "2015" @default.
• W2023245918 type Work @default.
• W2023245918 sameAs 2023245918 @default.
• W2023245918 citedByCount "41" @default.
• W2023245918 countsByYear W20232459182016 @default.
• W2023245918 countsByYear W20232459182017 @default.
• W2023245918 countsByYear W20232459182018 @default.
• W2023245918 countsByYear W20232459182019 @default.
• W2023245918 countsByYear W20232459182020 @default.
• W2023245918 countsByYear W20232459182021 @default.
• W2023245918 countsByYear W20232459182022 @default.
• W2023245918 countsByYear W20232459182023 @default.
• W2023245918 crossrefType "journal-article" @default.
• W2023245918 hasAuthorship W2023245918A5003181313 @default.
• W2023245918 hasAuthorship W2023245918A5007789858 @default.
• W2023245918 hasAuthorship W2023245918A5051333435 @default.
• W2023245918 hasAuthorship W2023245918A5083240638 @default.
• W2023245918 hasAuthorship W2023245918A5086987446 @default.
• W2023245918 hasConcept C103725303 @default.
• W2023245918 hasConcept C16685009 @default.
• W2023245918 hasConcept C178790620 @default.
• W2023245918 hasConcept C181199279 @default.
• W2023245918 hasConcept C185592680 @default.
• W2023245918 hasConcept C196843134 @default.
• W2023245918 hasConcept C2776690073 @default.
• W2023245918 hasConcept C2778177303 @default.
• W2023245918 hasConcept C2778810718 @default.
• W2023245918 hasConcept C48349386 @default.
• W2023245918 hasConcept C538909803 @default.
• W2023245918 hasConcept C55493867 @default.
• W2023245918 hasConcept C71924100 @default.
• W2023245918 hasConcept C79879829 @default.
• W2023245918 hasConcept C86803240 @default.
• W2023245918 hasConcept C87073359 @default.
• W2023245918 hasConcept C95444343 @default.
• W2023245918 hasConceptScore W2023245918C103725303 @default.
• W2023245918 hasConceptScore W2023245918C16685009 @default.
• W2023245918 hasConceptScore W2023245918C178790620 @default.
• W2023245918 hasConceptScore W2023245918C181199279 @default.

• next